- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03354403
Mothers Experiences With X-linked Retinoschisis Compared to Fathers Experiences
Mothers' Experiences With X-linked Retinoschisis Compared to Fathers' Experiences
Background:
X-linked retinoschisis (XLRS) is a genetic condition. It usually presents in boys in childhood with vision loss. Genetic conditions affect the people who have it and also their family members. Researchers want to learn if mothers and fathers react differently when a son gets XLRS. They also want to learn how personality impacts the way people react. This will help researchers find better ways to support families living with XLRS.
Objective:
To learn more about the experiences of mothers of sons with XLRS compared to fathers of sons with XLRS. Also to study personality differences between mothers and fathers.
Eligibility:
Parents of a biological son of any age with XLRS who is enrolled in protocol 03-EI-0033
Design:
Participants will be asked questions in person or by phone. This will last 30 90 minutes. They will be asked about their experience with XLRS and how it has impacted their family. The interview will be recorded.
Participants will complete a survey about personality traits. It will be anonymous. It can be completed by mail, email, or fax. It will take about 15 minutes.
Participants data may be shared with others, including those not at NIH, if they agree. Their data may be stored.
Sponsoring Institution: National Eye Institute
Study Overview
Status
Conditions
Detailed Description
OBJECTIVE: The objective of this study is to explore the experiences of mothers of sons with X-linked retinoschisis (XLRS) compared to fathers of sons with XLRS and to draft a personality profile of both mothers and fathers based on the findings.
<TAB>
STUDY POPULATION: Up to 50 mothers of sons of all ages diagnosed with XLRS are eligible to participate in this study. Up to 50 fathers of sons of all ages with XLRS are also eligible to participate and will serve as a comparison group.
DESIGN: This is a pilot mixed-methods study that involves a cross sectional qualitative interview and a self-administered questionnaire. Participants will be recruited through a "parent" study "Clinical and Molecular Studies of X-linked Retinoschisis" (03-EI-0033). Interviews will be conducted either in person at the National Institutes of Health Clinical Center (NIH CC) or by telephone. The interview will explore the experiences and impact of having a son with XLRS. Interviews will be recorded, transcribed verbatim, coded by two independent coders, and analyzed thematically. Participants will also be asked to complete a questionnaire to assess personality traits, anxiety, and optimism, using scales shown to be valid and reliable in the general population and in clinical samples. Results from these scales will provide information about variables that cannot be reliably assessed from an interview. This study is not designed to assess causality; rather, it will be used to generate hypotheses and inform future social and behavioral and/or basic science research studies of parents of sons with XLRS.
OUTCOME MEASURES: The primary outcomes of this study include a description of the experiences of mothers of sons with XLRS compared to fathers of sons with XLRS and a preliminary personality profile of mothers and fathers.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Maryland
-
Bethesda, Maryland, United States, 20892
- National Institutes of Health Clinical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
- INCLUSION CRITERIA:
Participants may be eligible to take part in this study if they: Have a biological son of any age with XLRS who is enrolled in XLRS Clinical and Molecular Studies protocol (03-EI-0033).
EXCLUSION CRITERIA:
-Participants may not be able to take part in this study if they:
- Are unable to understand and comply with the procedures of this study.
- Cannot communicate in English orally and in writing.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Patients
Up to 50 mothers of sons of all ages diagnosed with XLRS are eligible to participate in this study.
Up to 50 fathers of sons of all ages with XLRS are also eligible to participate and will serve as a comparison group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Description of the experiences of mothers of sons with XLRS compared to fathers of sons with XLRS
Time Frame: Study Completion
|
Study Completion
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 180016
- 18-EI-0016
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Retinoschisis
-
West China HospitalRecruiting
-
National Eye Institute (NEI)Recruiting
-
Applied Genetic Technologies CorpCompletedX-linked RetinoschisisUnited States
-
Zhongmou TherapeuticsRecruitingX-linked RetinoschisisChina
-
Shanghai General Hospital, Shanghai Jiao Tong University...Innostellar BiotherapeuticsRecruitingX-linked RetinoschisisChina
-
Aier School of Ophthalmology, Central South UniversityUnknownRetinal Disease | Macular RetinoschisisChina
-
VegaVect, Inc.National Eye Institute (NEI)Active, not recruiting
-
Atsena Therapeutics Inc.RecruitingX-linked RetinoschisisUnited States
-
Applied Genetic Technologies CorpFoundation Fighting BlindnessCompletedX-linked Retinoschisis | XLRSUnited States
-
Kyorin UniversityCompletedMacular Retinoschisis | Macular Detachment | Intrachoroidal CavitationJapan